MATERIAL TRANSFER AND OPTION AGREEMENT Carnegie Mellon University – Coya TherapeuticsMaterial Transfer and Option Agreement • December 5th, 2022 • Coya Therapeutics, Inc. • Pharmaceutical preparations
This Agreement (hereinafter this “Agreement”) is made and entered into this 24th day of June 2022 (“Effective Date”) by and between Carnegie Mellon University (hereinafter “Carnegie Mellon”), a Pennsylvania non-profit corporation having a principal place of business at 5000 Forbes Avenue, Pittsburgh, Pennsylvania 15213 and Coya Therapeutics, Inc., a Delaware corporation having a principal place of business at 5850 San Felipe St. Suite 500; Houston, TX 77057 (“Licensee”).
EXHIBIT A MATERIAL TRANSFER AND OPTION AGREEMENT This agreement is made and entered into as of the 23rd day of March, 1998, by and between Immtech International, Inc. ("IMMTECH"), a Delaware Corporation, maintaining an office at 1890 Maple Avenue,...Material Transfer and Option Agreement • September 28th, 1998 • Immtech International Inc
MATERIAL TRANSFER AND OPTION AGREEMENTMaterial Transfer and Option Agreement • August 9th, 2021 • Amplitude Healthcare Acquisition Corp • Biological products, (no disgnostic substances) • New York
This Material Transfer and Option Agreement (this “Agreement”) is made and entered into as of June 17, 2021 (the “Effective Date”) between Jasper Therapeutics, Inc., a Delaware corporation with a principal place of business at 2200 Bridge Pkwy Suit #102, Redwood City, CA 94065 (“Jasper”), and Aruvant Sciences GmbH, a company incorporated under the laws of Switzerland, having a place of business at Viaduktstrasse 8, 4051 Basel, Switzerland (“Aruvant”). Jasper and Aruvant are referred to each as a “Party” or collectively as the “Parties”, respectively.
